<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04749134</url>
  </required_header>
  <id_info>
    <org_study_id>CFTSp170</org_study_id>
    <nct_id>NCT04749134</nct_id>
  </id_info>
  <brief_title>MRI Development for Radiotherapy Planning and Delivery in Non-Patient Volunteers</brief_title>
  <acronym>MINION</acronym>
  <official_title>MRI Development for Radiotherapy Planning and Delivery in Non-Patient Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Christie NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Christie NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-patient volunteers will be scanned on the MR-Linac and MRSIM to facilitate the&#xD;
      development, optimisation and validation of MRI protocols at The Christie NHS Foundation&#xD;
      Trust.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Developed and optimised of MRI scanning sequences for use in clinical radiotherapy practice in MR guided radiotherapy</measure>
    <time_frame>Through study completion - up to 5 years</time_frame>
    <description>on-going development of MRI protocols to be released for clinical use</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Focus of the Study is MRI Sequence Development</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Personnel at The Christie NHS Foundation Trust&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing and able to provide written consent&#xD;
&#xD;
          -  Volunteers must undergo and satisfy MRI safety screening&#xD;
&#xD;
          -  Volunteers must be â‰¥ 16 years of age&#xD;
&#xD;
          -  Participants must agree to registration as a non-patient in CWP (the Trust's&#xD;
             Electronic Health Record - EHR- system) and have their MRIs read and reported for&#xD;
             incidental findings by a clinical radiologist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any contraindications to MRI identified after MRI safety screening including&#xD;
             completion of an MRI Safety Screening Form&#xD;
&#xD;
          -  Unable to tolerate MRI scan&#xD;
&#xD;
          -  Known Pregnancy&#xD;
&#xD;
          -  Known or suspected pathology in body region to be scanned&#xD;
&#xD;
          -  Member of study team&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Christie NHS FT</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Eccles, DPhil</last_name>
      <phone>16187999</phone>
      <email>cynhia.eccles1@nhs.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 27, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Christie NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Cynthia Eccles</investigator_full_name>
    <investigator_title>Head of Radiotherapy Research and Development</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

